Home > Category > Signaling Pathways > Cell Cycle > PERK > GSK2606414;GSK 2606414

GSK2606414;GSK 2606414

ChemLeader 98+%

Catalog No：CL1098 CAS No.：1337531-36-8 MDLNo： Formula：C24H20F3N5O MW：451.44

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
20 mg	3-5days	$500.00	Visible after login	- +
50 mg	3-5days	$550.00	Visible after login	- +
100 mg	3-5days	$800.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Certificate Of Authenticity(CPA)

Download COA

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	GSK2606414;GSK 2606414
CAS	1337531-36-8
Formula	C24H20F3N5O
MW	451.44
Appearance	white powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

GSK2606414 is an orally available, selective protein kinase R-like ER kinase (PERK) inhibitor with an IC₅₀ value of 0.4 nM. It can inhibit thapsigargin-induced PERK phosphorylation in lung carcinoma A549 cells and attenuates subcutaneous pancreatic human tumor xenograft growth in mice. Because PERK mediates the unfolded protein response pathway, which has roles in neurotoxicity and cancer, inhibition of PERK signaling has potential applications for the treatment of cancer and also cognitive degeneration.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CL1098

GSK2606414;GSK 2606414

1337531-36-8 98+%